Bionano Genomics
BNGO
62 hedge funds and large institutions have $12.3M invested in Bionano Genomics in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 8 closing their positions.
661% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $306K
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
35% more funds holding
Funds holding: 46 → 62 (+16)
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
5.72% less ownership
Funds ownership: 17.02% → 11.3% (-5.7%)
23% less capital invested
Capital invested by funds: $16M → $12.3M (-$3.68M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$895K |
| 2 |
Two Sigma Investments
New York
|
+$709K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$696K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$317K |
| 5 |
D.E. Shaw & Co
New York
|
+$299K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
-$1.07M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$620K |
| 3 |
State Street
Boston,
Massachusetts
|
-$454K |
| 4 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$429K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$373K |
BNGO Hedge Fund Activity: Q4 2023 in Review
62 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2023, worth a combined $12.3M — down 23% from $16M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new BNGO positions and 8 closed out — a net gain of 16 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $895K. The largest seller was Mitsubishi UFJ Asset Management, exiting entirely with an estimated $1.07M sold.
- 62 institutional investors held Bionano Genomics (BNGO) as of Q4 2023, up from 46 in Q3 2023.
- Funds reported $12.3M of Bionano Genomics stock for Q4 2023, down 23% quarter-over-quarter.
- 24 funds opened new Bionano Genomics positions in Q4 2023 and 8 closed out, a net change of +16 holders.
- The largest Bionano Genomics buyer in Q4 2023 was Renaissance Technologies, an estimated $895K added.
- The largest Bionano Genomics seller in Q4 2023 was Mitsubishi UFJ Asset Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2023.